Safe BBL: How I Reduce Risk in Brazilian Butt Lift Surgery

For several years, the Brazilian Butt Lift had the unfortunate distinction of carrying the highest mortality rate of any aesthetic surgical procedure — at one point estimated at 1 in 3,000 to 1 in 6,000 cases in some published series. That statistic, alarming on its own, reflected a specific, preventable cause: intramuscular or intravascular fat injection into the gluteal region. The problem wasn't the procedure concept itself. It was how the procedure was being performed.

The good news: we now understand the anatomy, the risk mechanism, and how to mitigate it. When performed according to current evidence-based safety protocols, BBL is a procedure I am comfortable offering and performing. This article explains exactly what those protocols are — and what questions you should be asking any surgeon before agreeing to this operation.

Understanding the Risk: Why BBL Was Dangerous

The fundamental risk of BBL is fat embolism — the inadvertent injection of fat into or adjacent to the venous system of the gluteal region, allowing fat particles to travel to the lungs and cause pulmonary fat embolism, a rapidly fatal event.

The gluteal region anatomy explains why this happened so frequently:

• The gluteal muscles contain large-calibre venous sinusoids — essentially large, low-pressure veins embedded within the muscle belly
• Injecting fat into the gluteus maximus or medius places the cannula tip directly adjacent to these vessels
• Positive injection pressure can drive fat particles directly into the venous circulation
• Even small volumes of fat entering the circulation can cause a fatal embolic event

A 2017 multi-society task force, a 2018 ASERF study, and subsequent cadaveric research all confirmed the same conclusion: deep intramuscular injection was the proximate cause of BBL-related deaths. The solution, therefore, is to avoid the muscle entirely.

The Evidence-Based Solution: Subcutaneous Fat Placement

The paradigm shift in safe BBL is straightforward: inject fat exclusively in the subcutaneous (sub-dermal) plane, not within the muscle.

The subcutaneous layer of the gluteal region — the fat compartment between the skin and the underlying muscle fascia — is entirely avascular relative to the intramuscular venous sinusoids. Properly placed subcutaneous fat injection poses an exponentially lower risk of intravascular entry.

The clinical evidence supports this unambiguously. A 2021 analysis of fatal BBL outcomes found that virtually all deaths were associated with intramuscular injection. Studies examining exclusively subcutaneous technique report dramatically lower complication rates. Major plastic surgery societies now universally recommend subcutaneous-only fat placement as the standard of care.

How I Use Ultrasound to Confirm Safe Injection Planes

The challenge with a purely anatomical approach is that the surgeon cannot see where the cannula tip is positioned within the tissue in real time. The gluteal anatomy varies between individuals — the depth of the fascia, the thickness of the subcutaneous compartment, and the contour of the muscles all differ.

My approach incorporates intraoperative ultrasound guidance as an additional safety layer. Here is how it works:

• The ultrasound probe is placed on the skin surface adjacent to the injection site, allowing real-time visualization of the cannula tip position
• The fascial layer is clearly identifiable on ultrasound as a bright, echogenic line separating the subcutaneous fat from the underlying muscle
• The cannula tip is tracked to confirm it remains above the fascia throughout the injection
• If the tip approaches or crosses the fascia, repositioning occurs before any injection

Ultrasound guidance transforms a "feel-based" plane identification into a visually confirmed certainty. It is the same principle that guides vascular access in intensive care: when you can see what you're doing, you dramatically reduce the risk of doing it wrong.

Multiple publications and the evolving position statements from the American Society of Plastic Surgeons and the Aesthetic Surgery Education and Research Foundation support ultrasound guidance as a meaningful safety adjunct in BBL. As with any technology, it does not replace technical skill — but it adds a real-time verified layer of safety that I consider non-negotiable for this procedure.

Additional Risk Reduction Measures I Implement

1. Blunt-Tipped Cannulas for Injection

Fat injection in the gluteal region is performed exclusively with blunt-tipped (not sharp) cannulas. Blunt tips are less likely to penetrate fascia or pierce vessel walls inadvertently. This is standard practice at my centre and should be for any surgeon performing BBL.

2. Small-Volume Incremental Injections with Movement

Continuous movement of the cannula during injection — rather than depositing a large bolus in a single location — distributes fat across a broad tissue plane. This avoids creating focal pressure that could drive fat toward fascial openings or vessel walls. Small-volume passes are far safer than large static injections.

3. Suprafascial Technique with Tactile Confirmation

Beyond ultrasound, I use the tactile feel of the tissue to continuously confirm cannula plane. The resistance characteristics of the subcutaneous compartment differ meaningfully from the intramuscular environment — and experienced hands recognize both. Ultrasound and tactile confirmation together create a redundant safety check.

4. No Prone Position Injection at Depth

There is evidence that certain patient positioning and injection angles increase the risk of inadvertent deep placement. My protocol avoids the high-risk injection trajectories identified in cadaveric and retrospective fatality studies.

5. Accredited Operating Facility, Experienced Team

BBL should never be performed in a non-accredited facility or without a certified anesthesiologist and appropriate emergency equipment. The BBL mortality data is heavily weighted toward unaccredited "surgical centres" — often offshore, often with no meaningful emergency response capability. Every BBL I perform is in an accredited facility with a full anesthesia team, appropriate monitoring, and the resources to manage any complication.

6. Appropriate Patient Selection

Not every patient requesting BBL is an appropriate candidate. I am conservative about operating on patients with BMIs on either extreme, significant cardiovascular risk factors, or anatomy that makes safe subcutaneous volume placement technically difficult. Saying no to a patient I cannot safely operate is not a failure — it is the job.

What You Should Ask Any Surgeon Before a BBL

If you are considering BBL anywhere — in Ottawa, or elsewhere — these are the questions I would want answered before agreeing to proceed:

1. "Where exactly will you be placing the fat?" The answer should be: exclusively subcutaneous, above the fascia. Any answer involving "deep into the muscle for more projection" should end the consultation.
2. "Do you use ultrasound guidance?" An increasing number of surgeons performing this procedure at high volume do. It is a meaningful safety addition.
3. "What facility will this be performed in?" It should be a licensed, accredited surgical centre. If it's a private office or unregulated clinic, that is a red flag.
4. "What is your training and certification?" Board-certified plastic surgeons with specific training in gluteal anatomy should be performing this procedure. Not every person who calls themselves a surgeon has equivalent training.
5. "What happens if something goes wrong?" There should be a clear answer: immediate emergency protocols, hospital privileges, and the ability to escalate care.

The Bottom Line

BBL is a procedure that can be performed safely. The evidence is clear, the risk mechanism is understood, and the technical solutions are available. The question is not whether BBL is inherently dangerous — it is whether the surgeon performing it is using the techniques that eliminate the primary cause of its known risk.

Subcutaneous injection, ultrasound confirmation, blunt cannulas, proper patient selection, and an accredited facility are not optional refinements — they are the minimum standard of care for this procedure as of 2026. If your surgeon cannot confirm all of these, look elsewhere.